318 related articles for article (PubMed ID: 18469844)
1. The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.
da Fonseca Pacheco D; Klein A; de Castro Perez A; da Fonseca Pacheco CM; de Francischi JN; Duarte ID
Br J Pharmacol; 2008 Jul; 154(5):1143-9. PubMed ID: 18469844
[TBL] [Abstract][Full Text] [Related]
2. Central antinociception induced by mu-opioid receptor agonist morphine, but not delta- or kappa-, is mediated by cannabinoid CB1 receptor.
Pacheco Dda F; Klein A; Perez AC; Pacheco CM; de Francischi JN; Reis GM; Duarte ID
Br J Pharmacol; 2009 Sep; 158(1):225-31. PubMed ID: 19594755
[TBL] [Abstract][Full Text] [Related]
3. Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit.
Slivicki RA; Saberi SA; Iyer V; Vemuri VK; Makriyannis A; Hohmann AG
J Pharmacol Exp Ther; 2018 Dec; 367(3):551-563. PubMed ID: 30275151
[TBL] [Abstract][Full Text] [Related]
4. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
[TBL] [Abstract][Full Text] [Related]
5. Tingenone, a pentacyclic triterpene, induces peripheral antinociception due to cannabinoid receptors activation in mice.
Veloso CC; Ferreira RCM; Rodrigues VG; Duarte LP; Klein A; Duarte ID; Romero TRL; Perez AC
Inflammopharmacology; 2018 Feb; 26(1):227-233. PubMed ID: 28889355
[TBL] [Abstract][Full Text] [Related]
6. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
Romero TR; Pacheco Dda F; Duarte ID
Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446
[TBL] [Abstract][Full Text] [Related]
7. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
Romero TR; Resende LC; Guzzo LS; Duarte ID
Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
[TBL] [Abstract][Full Text] [Related]
8. δ-Opioid receptor agonist SNC80 induces central antinociception mediated by Ca2+ -activated Cl- channels.
Pacheco Dda F; Pacheco CM; Duarte ID
J Pharm Pharmacol; 2012 Aug; 64(8):1084-9. PubMed ID: 22775211
[TBL] [Abstract][Full Text] [Related]
9. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
[TBL] [Abstract][Full Text] [Related]
10. Peripheral antinociception induced by δ-opioid receptors activation, but not μ- or κ-, is mediated by Ca²⁺-activated Cl⁻ channels.
Pacheco Dda F; Pacheco CM; Duarte ID
Eur J Pharmacol; 2012 Jan; 674(2-3):255-9. PubMed ID: 22134006
[TBL] [Abstract][Full Text] [Related]
11. delta-Opioid receptor agonist SNC80 elicits peripheral antinociception via delta(1) and delta(2) receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway.
Pacheco DF; Reis GM; Francischi JN; Castro MS; Perez AC; Duarte ID
Life Sci; 2005 Nov; 78(1):54-60. PubMed ID: 16135369
[TBL] [Abstract][Full Text] [Related]
12. Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
Haller VL; Cichewicz DL; Welch SP
Eur J Pharmacol; 2006 Sep; 546(1-3):60-8. PubMed ID: 16919265
[TBL] [Abstract][Full Text] [Related]
13. The Involvement of the Endocannabinoid System in the Peripheral Antinociceptive Action of Ketamine.
Ferreira RCM; Castor MGM; Piscitelli F; Di Marzo V; Duarte IDG; Romero TRL
J Pain; 2018 May; 19(5):487-495. PubMed ID: 29247851
[TBL] [Abstract][Full Text] [Related]
14. The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors.
Guindon J; Desroches J; Beaulieu P
Br J Pharmacol; 2007 Mar; 150(6):693-701. PubMed ID: 17179944
[TBL] [Abstract][Full Text] [Related]
15. Peltatoside Isolated from Annona crassiflora Induces Peripheral Antinociception by Activation of the Cannabinoid System.
Oliveira CD; Veloso CC; Ferreira RC; Lage GA; Pimenta LP; Duarte ID; Romero TR; Perez AC
Planta Med; 2017 Feb; 83(3-04):261-267. PubMed ID: 27574895
[TBL] [Abstract][Full Text] [Related]
16. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Dec; 600(1-3):50-8. PubMed ID: 18762181
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid modulation of cutaneous Adelta nociceptors during inflammation.
Potenzieri C; Brink TS; Pacharinsak C; Simone DA
J Neurophysiol; 2008 Nov; 100(5):2794-806. PubMed ID: 18784270
[TBL] [Abstract][Full Text] [Related]
18. Interactions between delta and mu opioid agonists in assays of schedule-controlled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys: studies with SNC80 [(+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and heroin.
Stevenson GW; Folk JE; Rice KC; Negus SS
J Pharmacol Exp Ther; 2005 Jul; 314(1):221-31. PubMed ID: 15792997
[TBL] [Abstract][Full Text] [Related]
19. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception.
Godoi MM; Junior HZ; da Cunha JM; Zanoveli JM
Pharmacol Biochem Behav; 2020 Jul; 194():172938. PubMed ID: 32376258
[TBL] [Abstract][Full Text] [Related]
20. Endogenous cannabinoids induce fever through the activation of CB1 receptors.
Fraga D; Zanoni CI; Rae GA; Parada CA; Souza GE
Br J Pharmacol; 2009 Aug; 157(8):1494-501. PubMed ID: 19681872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
